Respiratory Syncytial Virus Infections [clinicaltrials_resource:7c9505ceefd1b3ce11eae3aa4309af41]
Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [clinicaltrials:NCT00031473]Study to Evaluate MEDI-534 in Healthy Adults [clinicaltrials:NCT00111878]clinicaltrials:NCT00129766Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults [clinicaltrials:NCT00192465]Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 [clinicaltrials:NCT00192478]A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection [clinicaltrials:NCT00192504]A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT [clinicaltrials:NCT00232635]clinicaltrials:NCT00316264Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants [clinicaltrials:NCT00384462]Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy [clinicaltrials:NCT00420966]Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients [clinicaltrials:NCT00429637]Assessment of Airway Obstruction in Infants With Lower Respiratory Infections [clinicaltrials:NCT00435994]clinicaltrials:NCT00493285Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus [clinicaltrials:NCT00496821]Safety Study of Oral BTA9881 to Treat RSV Infection [clinicaltrials:NCT00504907]Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly [clinicaltrials:NCT00609635]Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT00658086]Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01065935]Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany [clinicaltrials:NCT01155193]RV568 - Viral Challenge With RSV [clinicaltrials:NCT01230645]Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine [clinicaltrials:NCT01290419]clinicaltrials:NCT01302418The Development of a Human Model of Respiratory Syncytial Virus Infection [clinicaltrials:NCT01349543]A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers [clinicaltrials:NCT01355016]Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children [clinicaltrials:NCT01459198]clinicaltrials:NCT01502072Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age [clinicaltrials:NCT01754428]Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01756482]Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01797419]RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections. [clinicaltrials:NCT01805921]Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [clinicaltrials:NCT01852266]Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children [clinicaltrials:NCT01893554]Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers [clinicaltrials:NCT01906164]Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial) [clinicaltrials:NCT01915394]RSV Observational Study 2 [clinicaltrials:NCT01922648]RSV F Dose-Ranging Study in Women [clinicaltrials:NCT01960686]Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [clinicaltrials:NCT01968083]Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children [clinicaltrials:NCT02040831]A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model [clinicaltrials:NCT02094365]A Study of ALS-008176 in Infants Hospitalized With RSV [clinicaltrials:NCT02202356]
condition [clinicaltrials_vocabulary:condition]
Prevention of RSV Infections in Bone Marrow Transplant Recipients [clinicaltrials:NCT00001903]Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [clinicaltrials:NCT00031473]Study to Evaluate MEDI-534 in Healthy Adults [clinicaltrials:NCT00111878]clinicaltrials:NCT00129766Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults [clinicaltrials:NCT00192465]Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 [clinicaltrials:NCT00192478]A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection [clinicaltrials:NCT00192504]A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT [clinicaltrials:NCT00232635]clinicaltrials:NCT00316264Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants [clinicaltrials:NCT00384462]Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy [clinicaltrials:NCT00420966]Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients [clinicaltrials:NCT00429637]Assessment of Airway Obstruction in Infants With Lower Respiratory Infections [clinicaltrials:NCT00435994]clinicaltrials:NCT00493285Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus [clinicaltrials:NCT00496821]Safety Study of Oral BTA9881 to Treat RSV Infection [clinicaltrials:NCT00504907]clinicaltrials:NCT00585481clinicaltrials:NCT00593918Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly [clinicaltrials:NCT00609635]Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT00658086]clinicaltrials:NCT01006629Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01065935]clinicaltrials:NCT01075178Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study [clinicaltrials:NCT01090557]clinicaltrials:NCT01107535Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany [clinicaltrials:NCT01155193]RV568 - Viral Challenge With RSV [clinicaltrials:NCT01230645]Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine [clinicaltrials:NCT01290419]clinicaltrials:NCT01297504clinicaltrials:NCT01302418The Development of a Human Model of Respiratory Syncytial Virus Infection [clinicaltrials:NCT01349543]A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers [clinicaltrials:NCT01355016]Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children [clinicaltrials:NCT01459198]clinicaltrials:NCT01466062Intra-nasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01475305]ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers [clinicaltrials:NCT01483911]clinicaltrials:NCT01502072Surveillance of Synagis in Korean Pediatric Patients [clinicaltrials:NCT01537198]Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age [clinicaltrials:NCT01754428]Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01756482]
condition browse [clinicaltrials_vocabulary:condition-browse]
Prevention of RSV Infections in Bone Marrow Transplant Recipients [clinicaltrials:NCT00001903]Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [clinicaltrials:NCT00031473]Study to Evaluate MEDI-534 in Healthy Adults [clinicaltrials:NCT00111878]clinicaltrials:NCT00129766Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults [clinicaltrials:NCT00192465]Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 [clinicaltrials:NCT00192478]A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection [clinicaltrials:NCT00192504]A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT [clinicaltrials:NCT00232635]clinicaltrials:NCT00316264Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants [clinicaltrials:NCT00384462]Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy [clinicaltrials:NCT00420966]Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients [clinicaltrials:NCT00429637]Assessment of Airway Obstruction in Infants With Lower Respiratory Infections [clinicaltrials:NCT00435994]clinicaltrials:NCT00493285Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus [clinicaltrials:NCT00496821]Safety Study of Oral BTA9881 to Treat RSV Infection [clinicaltrials:NCT00504907]clinicaltrials:NCT00585481clinicaltrials:NCT00593918Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly [clinicaltrials:NCT00609635]Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT00658086]clinicaltrials:NCT01006629Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01065935]clinicaltrials:NCT01075178Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study [clinicaltrials:NCT01090557]clinicaltrials:NCT01107535Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany [clinicaltrials:NCT01155193]RV568 - Viral Challenge With RSV [clinicaltrials:NCT01230645]Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine [clinicaltrials:NCT01290419]clinicaltrials:NCT01297504clinicaltrials:NCT01302418The Development of a Human Model of Respiratory Syncytial Virus Infection [clinicaltrials:NCT01349543]A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers [clinicaltrials:NCT01355016]Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children [clinicaltrials:NCT01459198]clinicaltrials:NCT01466062Intra-nasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01475305]ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers [clinicaltrials:NCT01483911]clinicaltrials:NCT01502072Surveillance of Synagis in Korean Pediatric Patients [clinicaltrials:NCT01537198]Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age [clinicaltrials:NCT01754428]Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT01756482]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Respiratory Syncytial Virus Infections [clinicaltrials_resource:7c9505ceefd1b3ce11eae3aa4309af41]
Bio2RDF identifier
7c9505ceefd1b3ce11eae3aa4309af41
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7c9505ceefd1b3ce11eae3aa4309af41
identifier
clinicaltrials_resource:7c9505ceefd1b3ce11eae3aa4309af41
title
Respiratory Syncytial Virus Infections
@en
type
label
Respiratory Syncytial Virus In ...... 505ceefd1b3ce11eae3aa4309af41]
@en
Respiratory Syncytial Virus Infections